Planet Microcap Podcast | Microcap Investing Strategies

My guest on the show today is Joe Lucosky, Managing Partner at Lucosky Brookman. You might take one look at this title and might not think this is for you; as an investor you might wonder why should you care whether a company decides to uplist, cross-list or even delist? What do these terms even mean? Why is the company wasting their time even considering any of these corporate actions? If you've ever asked yourself this question, whether you're an investor or even an issuer, this is without a doubt the episode for you. Even if you've never thought about these topics, I think you'll find our conversation fascinating. In the world of Micro and Nano-caps, this conversation is happening in every boardroom: should we uplist to the NASDAQ from OTC Markets? What's this new U.S. Listings program at CBOE? Should we delist to the OTCQX, QB or the Pinks? Is it too soon for us to Uplist? Should we cross-list onto OTC or NASDAQ? Should we do a simultaneous raise with uplist or cross-list? How will our investors react to